- Nano Express
- Open Access
Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells
© Gurunathan et al.; licensee Springer. 2015
Received: 8 December 2014
Accepted: 10 January 2015
Published: 5 February 2015
Silver nanoparticles (AgNPs) are prominent group of nanomaterials and are recognized for their diverse applications in various health sectors. This study aimed to synthesize the AgNPs using the leaf extract of Artemisia princeps as a bio-reductant. Furthermore, we evaluated the multidimensional effect of the biologically synthesized AgNPs in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma (A549) cells. UV-visible (UV–vis) spectroscopy confirmed the synthesis of AgNPs. X-ray diffraction (XRD) indicated that the AgNPs are specifically indexed to a crystal structure. The results from Fourier transform infrared spectroscopy (FTIR) indicate that biomolecules are involved in the synthesis and stabilization of AgNPs. Dynamic light scattering (DLS) studies showed the average size distribution of the particle between 10 and 40 nm, and transmission electron microscopy (TEM) confirmed that the AgNPs were significantly well separated and spherical with an average size of 20 nm. AgNPs caused dose-dependent decrease in cell viability and biofilm formation and increase in reactive oxygen species (ROS) generation and DNA fragmentation in H. pylori and H. felis. Furthermore, AgNPs induced mitochondrial-mediated apoptosis in A549 cells; conversely, AgNPs had no significant effects on L132 cells. The results from this study suggest that AgNPs could cause cell-specific apoptosis in mammalian cells. Our findings demonstrate that this environmentally friendly method for the synthesis of AgNPs and that the prepared AgNPs have multidimensional effects such as anti-bacterial and anti-biofilm activity against H. pylori and H. felis and also cytotoxic effects against human cancer cells. This report describes comprehensively the effects of AgNPs on bacteria and mammalian cells. We believe that biologically synthesized AgNPs will open a new avenue towards various biotechnological and biomedical applications in the near future.
Nanomaterials often have novel and size-related physico-chemical properties that differ significantly from their larger counterparts. Therefore, the growing interest in the field has driven the production of numerous nanomaterials with outstanding optical, magnetic, catalytic, and electrical properties [1,2]. Silver nanoparticles (AgNPs) have become increasingly popular and have been used in various applications such as antibiotic agents in textiles and wound dressings and in biomedical devices; furthermore, they are one of the most commonly used engineered nanoparticles in commercialized products [3,4]. Since AgNPs have widespread applications, academia and industry have paid more attention to the production of AgNPs than to their uses .
Among several methods, chemical methods provide an easy way to synthesize AgNPs in solution, and they are a commonly used method for the production of AgNPs . In contrast, physical methods appear to produce a low yield. Chemical methods, on the other hand, are more complex in that they require three main components, including metal precursors, reducing agents, and stabilizing/capping agents. Furthermore, chemical methods use various toxic materials including hydrazine, citrate, borohydride, or other organic compounds (e.g., reducing agents); all these agents can be toxic to living organisms including humans. Capping agents are playing an important role for the stabilization of nanoparticles, for example, capped AgNPs exhibit better antibacterial activity than uncapped AgNPs do [6,7]. Biological methods seem to be valuable for the preparation of AgNPs with controlled size and shape of the nanoparticles [8-13]. Given that conventional physical methods have low yields and chemical methods are toxic and consume a lot of energy, the development of environmentally friendly approaches has become the more preferred trend for the field of nanobiotechnology. Biologically prepared nanomaterials are extremely valuable because nanoparticles are easily soluble and stable . In addition, during the biological synthesis of AgNPs, the reducing agent and stabilizer are replaced by molecules produced by living organisms. These molecular compounds can be sourced from various living organisms such as bacteria, fungi, yeasts, algae, or plants . Biomolecules can be attached to various types of surfaces via diffusion, adsorption/absorption, covalent cross-linking, and affinity interaction .
Recently, numerous microorganisms have been reported to synthesize AgNPs, including bacteria like Pseudomonas stutzeri AG259 , Bacillus licheniformis , Brevibacterium casei , Escherichia coli , and Shewanella oneidensis  and fungi like Fusarium oxysporum , Trichoderma viride , and Ganoderma neo-japonicum . Extracellular synthesis of various types of nanoparticles was performed using plants, including geranium leaves  and lemongrass , via the reduction of aqueous AgNO3 and AuCl4, respectively. Previous studies suggest that leaf and other parts of plant extracts from various plants, such as Azadirachta indica , Aloe vera , Bryophyllum sp. , Gliricidia sepium, Alfalfa sprouts [27,28], aqueous stem extract of banana , and Allophylus cobbe , have also been explored for the synthesis of AgNPs. Compared to other reducing agents derived from microorganisms, the reduction of the Ag+ ions with the extracts of plants occurs quickly . Furthermore, biological methods seem to have less time required for complete reduction and be stable and readily available in solution at high densities . Similarly, shape and size, the rate of reduction of metal ions is faster, and more stable metal nanoparticles are formed using leaf extracts compared to using microorganisms [28,30].
The green juice of Artemisia princeps used to treat skin injuries and gastrointestinal disorders [31,32]. Yun et al.  have identified 16 water-soluble phenolic compounds in the leaf water extract of A. princeps, and its extract contains 192 volatile chemicals . Therefore, this plant extract can be used as a reducing and stabilizing agent for the synthesis of AgNPs.
Infections caused by multidrug-resistant bacteria lead to major public health issues, such as morbidity, mortality, cost of health care, and the need for implementation of infection control measures . Parsonnet et al.  reported that bacteria have been linked to cancer by the induction of chronic inflammation and the production of carcinogenic bacterial metabolites. A pertinent example of the inflammatory mechanism of carcinogenesis is the Helicobacter pylori infection. H. pylori are known to cause infection in the stomach and are found in about two thirds of the world’s population. H. pylori exist and are adherent to the epithelium of stomach. Non-pylori gastric Helicobacter organisms cause chronic gastritis and inflammation in humans . On the other hand, Fusobacterium nucleatum promotes colorectal carcinogenesis and intestinal tumorigenesis and modulates the tumor-immune microenvironment [37,38].
Recent surveys suggest that lung cancer accounts for 23% of all cancer-related mortality, outnumbering the total mortality of breast, colon, and prostate cancers combined [39,40]. To address the effect of AgNPs, several studies have reported the impact of AgNPs in various cell lines, such as BRL4A rat liver cells , PC-12 neuroendocrine cells , germ line stem cells , rat alveolar macrophages , and a human lung carcinoma cell line, A549 . Recent studies reported that biologically prepared AgNPs have been used for antibacterial and antifungal [46-48]. The results from previous studies suggest that the generation of reactive oxygen species (ROS) is an important and general mechanism of nanoparticle-mediated cytotoxicity through DNA damage, apoptosis, and necrosis [44,49-53]. Although various studies have addressed the effect of AgNPs in various cell lines, there has been no study on the multiple functions of biologically prepared AgNPs using A. princeps on bacteria causing carcinogenesis and human cancer cells. Therefore, this study was aimed to investigate the following objectives. Firstly, we aimed to develop an easy, consistent, cost-effective, and green approach to the synthesis of colloidal AgNPs using leaf extract of A. princeps. Secondly, we evaluated the antibacterial and anti-biofilm activity of AgNPs against H. pylori and non-pylori Helicobacter felis. Finally, we assessed the cell-specific cytotoxic effects of AgNPs in normal lung and lung cancer cells.
Bacterial strains and reagents
All culture media and chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. The strains of H. pylori GS-13 and H. felis GS-14 used in the present study were obtained from our culture collection. All strains were maintained at −80°C in Brucella agar (BA) (Sigma, Cream Ridge, NJ, USA) supplemented with 2% fetal calf serum (FCS). Penicillin-streptomycin solution, trypsin-EDTA solution, RPMI 1640 medium, and 1% antibiotic-antimycotic solution were obtained from Life Technologies/Gibco (Grand Island, NY, USA). Silver nitrate, fetal bovine serum (FBS), and the in vitro toxicology assay kit were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Synthesis and characterization of AgNPs
A. princeps leaves were collected from plants growing in the Jeju Island, South Korea, and stored at 4°C until needed. The leaf extract was prepared according to method described earlier . Briefly, the filtered extract was used for the synthesis of AgNPs by adding 10 mL (1 mg/mL) to 100 mL of 1 mM AgNO3 in an aqueous solution at room temperature. The bio-reduction of the AgNO3 was monitored spectrophotometrically between 300 and 600 nm. The synthesized particles were characterized according to methods described previously . The size distribution of the dispersed particles was measured using a Zetasizer Nano ZS90 (Malvern Instruments Ltd., Malvern, UK). X-ray diffraction (XRD) analyses were carried out on an X-ray diffractometer (Bruker D8 DISCOVER; Bruker AXS GmBH, Karlsruhe, Germany). The high-resolution XRD patterns were measured at 3 Kw with a Cu target using a scintillation counter (λ = 1.5406 °A) at 40 kV and 40 mA and were recorded in the range of 2θ = 5°–80°. Further characterization of changes in the surface and surface composition was performed by Fourier transform infrared spectroscopy (PerkinElmer Spectroscopy GX, PerkinElmer, Waltham, MA, USA). Transmission electron microscopy (TEM), using a JEM-1200EX microscope, was performed to determine the size and morphology of AgNPs. TEM images of AgNPs were obtained at an accelerating voltage of 300 kV.
Determination of minimum inhibitory concentrations of AgNPs and in vitro killing assay
Minimal inhibitory concentration (MIC) of H. pylori and H. felis was determined as described previously . To determine the MICs of AgNPs, H. pylori and H. felis were then exposed to different concentrations of AgNPs. Growth was monitored using a microtiter ELISA reader (EMax, Molecular Devices, Sunnyvale, CA, USA) by monitoring the absorbance at 600 nm. The MIC of AgNPs was defined as the lowest concentration that inhibited the visible growth of bacteria. The in vitro killing assay was performed as described previously .
Determination of biofilm activity using the tissue culture plate method
Inhibition of biofilm was determined as described earlier with suitable modifications [8,55]. Briefly, the cells were grown in Brucella broth supplemented with 2% FCS and individual wells of sterile, 96-well flat-bottom polystyrene tissue culture plates (TCPs) were filled with 180 μL of a single bacterial species (1 × 106/mL). The cell culture plates were then incubated with AgNPs for 24 h at 37°C. After incubation, the media were removed, and the wells were washed three times with 200 μL sterile distilled water to remove non-adherent bacteria. The crystal violet solutions in water were added for 45 min. The wells were then washed five times with 300 μL of sterile distilled water to remove excess stain. The absorbance of each well was measured at 595 nm using a microtiter ELISA reader. The percent inhibition of biofilm activity was calculated as described earlier [8,55].
Measurement of ROS generation in bacteria
ROS was determined according to the manufacturer’s instructions and according to previous publications [8,49,56]. All test strains were grown in BB. Cell suspensions were incubated with AgNPs at 37°C on a rotary shaker for 12 h. Aliquots were then removed and spun in a microfuge, and the absorption of the supernatant was measured at 450 nm.
Human lung cancer A549 cells and normal human lung L-132 cells were obtained from the Korean Cell Bank (Seoul, Korea) and cultured in RPMI 1640 medium supplemented with 10% FBS and 100 U/mL penicillin-streptomycin at 5% CO2 and 37°C. At 75% confluence, the cells were harvested using 0.25% trypsin and subcultured in 75-cm2 flasks, 6-well plates, or 96-well plates. Cells were allowed to attach the surface for 24 h before treatment. The medium was replaced three times per week, and the cells were passaged at subconfluency.
Cell viability and cytotoxicity assays
Cell viability was measured using a Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Kumamoto, Japan). Briefly, A549 and L132 cells were plated onto 96-well flat-bottom culture plates with various concentrations of AgNPs. All cultures were incubated for 24 h at 37°C (5% CO2 in a humidified incubator). CCK-8 solution (10 μL) was added to each well, and the plate was incubated for another 2 h at 37°C. Absorbance was measured at 450 nm with a microplate reader (Multiskan FC; Thermo Fisher Scientific Inc., Waltham, MA, USA). Cytotoxicity was assessed using supernatants from the medium in lactate dehydrogenase (LDH) assays. An LDH Cytotoxicity Detection kit (Takara Bio Inc., Tokyo, Japan) was used according to the manufacturer’s protocol, and the absorbance was measured at 490 nm using a microplate reader.
ROS (H2-DCFH-DA) assay
Human lung normal L132 cells and A549 human lung epithelial adenocarcinoma cells were cultured in minimum essential medium (Hyclone Laboratories, Logan, UT, USA) containing 10 μM H2-DCFDA in a humidified incubator at 37°C for 30 min. Cells were washed in PBS (pH 7.4) and lysed in lysis buffer (25 mM HEPES [pH 7.4], 100 mM NaCl, 1 mM EDTA, 5 mM MgCl2, and 0.1 mM DTT supplemented with a protease inhibitor cocktail). Cells were cultured on coverslips in a 4-well plate. Cells were incubated in DMEM containing 10 μM H2-DCFDA at 37°C for 30 min. Cells were washed in PBS, mounted with Vectashield fluorescent medium, and viewed with a fluorescence microscope.
The change in mitochondrial transmembrane potential was evaluated using the cationic fluorescent indicator JC-1 (Molecular Probes, Eugene, OR, USA). J-aggregates of intact mitochondria were fluorescent red with an emission at 583 nm, and J-monomers in the cytoplasm were fluorescent green with emission at 525 nm and an excitation wavelength of 488 nm. A549 and L132 cells were incubated in RPMI containing 10 μM JC-1 at 37°C for 15 min, washed with PBS, and transferred to a clear 96-well plate. Cells were also cultured on cover slips, incubated in DMEM containing 10 μM JC-1 at 37°C for 15 min, and then washed with PBS. Finally, cells were mounted using Vectashield fluorescent medium and visualized with fluorescence microscopy.
All assays were carried out in triplicate and the experiments were repeated at least three times. The results are presented as means ± SD. All experimental data were compared using Student’s t-test. A p value less than 0.05 was considered statistically significant.
Results and discussion
Synthesis and characterization of AgNPs using leaf extract
XRD analysis of AgNPs
FTIR spectra of AgNPs
Dynamic light scattering analysis of AgNPs
Size and surface analysis of AgNPs by TEM
Determination of MIC of AgNPs against H. pylori and H. felis
In response to the overwhelming evidence linking H. pylori infection to human cancer, the International Agency for Research on Cancer listed H. pylori as a definite human oncogenic agent in 1994 [36,73-75]. Therefore, we were interested in finding out the MIC of AgNPs against both pylori and non-pylori strains, such as H. pylori and H. felis, respectively. The MIC of AgNPs was defined as the lowest concentration that completely inhibited visible growth of bacteria after incubation at 37°C for 24 h. In these studies, H. pylori and H. felis were used as a model bacteria for Gram negative to evaluate antibacterial activities of AgNPs. Both strains were incubated with the different concentration of AgNPs for 24 h in Brucella broth. The media without AgNPs were used as a control. The H. pylori and H. felis bacterial counts were significantly reduced by the treatment with AgNPs than control. The level of MIC of AgNPs was found to be 5.0 and 5.5 μg/mL to H. pylori and H. felis, respectively. The toxic effects of AgNPs depend on size, surface area, and surface functionalization which are major factors that influence bio-kinetics and toxicity in bacteria [76,77].
Dose-dependent antibacterial effects of AgNPs
Time-dependent antibacterial activity of AgNPs
Anti-biofilm activity of AgNPs against H. pylori
Effect of AgNPs on ROS production
ROS is a natural by-product of the metabolism of respiring organisms . Induction of ROS synthesis leads to the formation of highly reactive radicals that destroy the cells. The possible mechanisms of H. pylori and H. felis cell death are due to membrane damage by AgNPs which relates to metal depletion, that is, the formation of pits in the outer membrane and change in membrane permeability by the progressive release of lipopolysaccharide (LPS) molecules and membrane proteins . Previous studies proposed that the sites of interaction for AgNPs and membrane cells might be due to sulfur-containing proteins present in the bacterial membrane proteins [91-95]. Previous studies suggest that ROS may be a common mechanism of cell death induced by bactericidal antibiotics [96-99].
Effect of AgNPs on cell viability of L132 and A549 cells
Effect of AgNPs membrane leakage
AgNPs induce time-dependent ROS generation
AgNPs induce mitochondrial-mediated apoptosis
We have demonstrated an easy, simple, and environmentally friendly approach to the synthesis of AgNPs using the leaf extract of A. princeps as a reducing and stabilizing agent. In this method, highly crystalline, spherical-shaped AgNPs with an average size of 20 nm were prepared without using any harmful reducing or capping agents. The phyto-molecules of the A. princeps extract were not only responsible for the reduction of AgNO3 but also function as capping agents to the surfaces of the AgNPs. The novel AgNPs show multifunctional effects against bacteria and human cancer cells, yet were biocompatible with normal lung cells. This suggests that AgNPs could contribute to develop therapeutic molecules for anticancer and anti-angiogenic. Interestingly, this comprehensive report describes the effect of AgNPs in bacteria and human cell types. Our results highlight a common and possible mechanism of cell death in bacteria and human cancer cells that is due to the generation of ROS, eventually leading to cell death. We believe that biologically prepared AgNPs could open a new avenue for various biomedical applications, particularly infections and cancer.
This work was supported by the KU-Research Professor Program of Konkuk University. Dr Sangiliyandi Gurunathan was supported by a Konkuk University KU-Full-Time Professorship. This work was carried out by Woo Jang-Choon project (PJ007849) from the Rural Development Administration (RDA), Republic of Korea.
- Ju-Nam Y, Lead JR. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications. Science Total Environment. 2008;400:396–414.View ArticleGoogle Scholar
- Nelson DJ, Strano M. Richard Smalley: saving the world with nanotechnology. Nat Nanotechnol. 2006;1:96–7.View ArticleGoogle Scholar
- Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176:1–12.View ArticleGoogle Scholar
- Stensberg MC, Wei QS, McLamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine. 2011;6:879–98.View ArticleGoogle Scholar
- Tran QH, Nguyen VQ, Le AT. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci: Nanosci Nanotechnol. 2013;4:033001 (20 pp).Google Scholar
- Abdel-Mohsen AM, Hrdina R, Burgert L, Abdel-Rahman RM, Hasova M, Smejkalova D, et al. Antibacterial activity and cell viability of hyaluronan fiber with silver nanoparticles. Carbohydr Polym. 2013;92:1177–87.View ArticleGoogle Scholar
- Gnanadhas DP, Ben Thomas M, Thomas R, Raichur AM, Chakravortty D. Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother. 2013;57:4945–55.View ArticleGoogle Scholar
- Gurunathan S, Han JW, Kwon DN, Kim JH. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett. 2014;9:373.View ArticleGoogle Scholar
- Gurunathan S, Kalishwaralal K, Vaidyanathan R, Deepak V, Pandian SRK, Muniyandi J, et al. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surfaces B-Biointerfaces. 2009;74:328–35.View ArticleGoogle Scholar
- Kalimuthu K, Babu RS, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surfaces B-Biointerfaces. 2008;65:150–3.View ArticleGoogle Scholar
- Malik MA, O’Brien P, Revaprasadu N. A simple route to the synthesis of core/shell nanoparticles of chalcogenides. Chem Mater. 2002;14:2004–10.View ArticleGoogle Scholar
- Parikh RY, Singh S, Prasad BLV, Patole MS, Sastry M, Shouche YS. Extracellular synthesis of crystalline silver nanoparticles and molecular evidence of silver resistance from Morganella sp.: towards understanding biochemical synthesis mechanism. ChemBioChem. 2008;9:1415–22.View ArticleGoogle Scholar
- Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomedicine-Nanotechnology Biol Med. 2010;6:257–62.View ArticleGoogle Scholar
- Emerich DF, Thanos CG. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Eng. 2006;23:171–84.View ArticleGoogle Scholar
- Sintubin L, Verstraete W, Boon N. Biologically produced nanosilver: current state and future perspectives. Biotechnol Bioeng. 2012;109:2422–36.View ArticleGoogle Scholar
- Choi Y, Jeong Y, Chung H, Ito E, Hara M, Noh J. Formation of ordered self-assembled monolayers by adsorption of octylthiocyanates on Au(111). Langmuir. 2007;24:91–6.View ArticleGoogle Scholar
- Klaus T, Joerger R, Olsson E, Granqvist CG. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci U S A. 1999;96:13611–4.View ArticleGoogle Scholar
- Kalishwaralal K, Deepak V, Ram Kumar Pandian S, Kottaisamy M, BarathmaniKanth S, Kartikeyan B, et al. Biosynthesis of silver and gold nanoparticles using Brevibacterium casei. Colloids Surf B: Biointerfaces. 2010;77:257–62.View ArticleGoogle Scholar
- Suresh AK, Pelletier DA, Wang W, Moon JW, Gu B, Mortensen NP, et al. Silver nanocrystallites: biofabrication using Shewanella oneidensis, and an evaluation of their comparative toxicity on gram-negative and gram-positive bacteria. Environ Sci Technol. 2010;44:5210–5.View ArticleGoogle Scholar
- Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B: Biointerfaces. 2003;28:313–8.View ArticleGoogle Scholar
- Fayaz M, Tiwary CS, Kalaichelvan PT, Venkatesan R. Blue orange light emission from biogenic synthesized silver nanoparticles using Trichoderma viride. Colloids Surf B: Biointerfaces. 2010;75:175–8.View ArticleGoogle Scholar
- Shankar SS, Ahmad A, Sastry M. Geranium leaf assisted biosynthesis of silver nanoparticles. Biotechnol Prog. 2003;19:1627–31.View ArticleGoogle Scholar
- Shankar SS, Rai A, Ahmad A, Sastry M. Controlling the optical properties of lemongrass extract synthesized gold nanotriangles and potential application in infrared-absorbing optical coatings. Chem Mater. 2005;17:566–72.View ArticleGoogle Scholar
- Shankar SS, Rai A, Ahmad A, Sastry M. Rapid synthesis of Au, Ag, and bimetallic Au core-Ag shell nanoparticles using Neem (Azadirachta indica) leaf broth. J Colloid Interface Sci. 2004;275:496–502.View ArticleGoogle Scholar
- Chandran SP, Chaudhary M, Pasricha R, Ahmad A, Sastry M. Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract. Biotechnol Prog. 2006;22:577–83.View ArticleGoogle Scholar
- Baishya D, Sharma N, Bora R. Green synthesis of silver nanoparticle using Bryophyllum pinnatum (Lam.) and monitoring their antibacterial activities. Scholars Res. Library. 2012;4:2098–104.Google Scholar
- Raut RW, Lakkakula JR, Kolekar NS, Mendhulkar VD, Kashid SB. Phytosynthesis of silver nanoparticle using Gliricidia sepium (Jacq.). Curr Nanosci. 2009;5:117–22.View ArticleGoogle Scholar
- Gardea-Torresdey JL, Gomez E, Peralta-Videa JR, Parsons JG, Troiani H, Jose-Yacaman M. Alfalfa sprouts: a natural source for the synthesis of silver nanoparticles. Langmuir. 2003;19:1357–61.View ArticleGoogle Scholar
- Das J, Velusamy P. Biogenic synthesis of antifungal silver nanoparticles using aqueous stem extract of banana. Nano Biomed Eng. 2013;5:34–8.Google Scholar
- Khalil NM, de Mattos AC, Carraro TCMM, Ludwig DB, Mainardes RM. Nanotechnological strategies for the treatment of neglected diseases. Curr Pharm Des. 2013;19:7316–29.View ArticleGoogle Scholar
- Umano K, Hagi Y, Nakahara K, Shoji A, Shibamoto T. Volatile chemicals identified in extracts from leaves of Japanese mugwort (Artemisia princeps Pamp). J Agric Food Chem. 2000;48:3463–9.View ArticleGoogle Scholar
- Kim YS, Lee JH, Kim MN, Lee WG, Kim JO. Volatile flavour compounds from raw mugwort leaves and parched mugwort. J Korean Soc Food Sci Nutr. 1994;23:261–4.Google Scholar
- Yun KW, Kil BS, Park JS. Identification of naturally occurring, chemicals from Artemis, princeps var, orientalis. Allelopathy J. 1994;1:95–104.Google Scholar
- Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009;59 Suppl 1:S4–16.View ArticleGoogle Scholar
- Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect. 1995;103 Suppl 8:263–8.View ArticleGoogle Scholar
- Chang AH, Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev. 2010;23:837−+.View ArticleGoogle Scholar
- Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195–206.View ArticleGoogle Scholar
- Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–15.View ArticleGoogle Scholar
- Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G. Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett. 2013;3:45.View ArticleGoogle Scholar
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.View ArticleGoogle Scholar
- Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol Vitro. 2005;19:975–83.View ArticleGoogle Scholar
- Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci. 2006;92:456–63.View ArticleGoogle Scholar
- Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88:412–9.View ArticleGoogle Scholar
- Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Physical Chem B. 2008;112:13608–19.View ArticleGoogle Scholar
- Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85:743–50.View ArticleGoogle Scholar
- Tripathi RM, Rana D, Shrivastav A, Singh RP, Shrivastavd BR. Biogenic synthesis of silver nanoparticles using Saraca indica leaf extract and evaluation of their antibacterial activity. Nano Biomed Eng. 2013;5:50–6.Google Scholar
- Abdeen S, Rimal Isaac RS, Geo S, Sornalekshmi S, Rose A, Praseetha PK. Evaluation of antimicrobial activity of biosynthesized iron and silver nanoparticles using the fungi Fusarium oxysporum and Actinomycetes sp. On human pathogens. Nano Biomed Eng. 2013;5:39–45.Google Scholar
- Li C, Wang XS, Chen F, Zhang CL, Zhi X, Wang K, et al. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials. 2013;34:3882–90.View ArticleGoogle Scholar
- Gurunathan S, Raman J, Malek NA, John PA, Vikineswary S. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int J Nanomedicine. 2013;8:4399–413.Google Scholar
- Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett. 2008;179:93–100.View ArticleGoogle Scholar
- AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279–90.View ArticleGoogle Scholar
- Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol Vitro. 2009;23:1076–84.View ArticleGoogle Scholar
- Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190:156–62.View ArticleGoogle Scholar
- Gurunathan S, Han JW, Eppakayala V, Dayem AA, Kwon DN, Kim JH. Biocompatibility effects of biologically synthesized graphene in primary mouse embryonic fibroblast cells. Nanoscale Res Lett. 2013;8:393.View ArticleGoogle Scholar
- Yonezawa H, Osaki T, Kurata S, Zaman C, Hanawa T, Kamiya S. Assessment of in vitro biofilm formation by Helicobacter pylori. J Gastroenterol Hepatol. 2010;25 Suppl 1:S90–4.View ArticleGoogle Scholar
- Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine. 2012;7:5901–14.View ArticleGoogle Scholar
- Shameli K, Ahmad MB, Yunus WM, Ibrahim NA, Gharayebi Y, Sedaghat S. Synthesis of silver/montmorillonite nanocomposites using gamma-irradiation. Int J Nanomedicine. 2010;5:1067–77.Google Scholar
- Awwad A, Salem N, Abdeen A. Green synthesis of silver nanoparticles using carob leaf extract and its antibacterial activity. Int J Industr Chem. 2013;4:1–6.View ArticleGoogle Scholar
- Mukherjee S, Chowdhury D, Kotcherlakota R, Patra S, Vinothkumar B, Bhadra MP, et al. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics. 2014;4:316–35.View ArticleGoogle Scholar
- Tavitian BA, Nabedryk E, Mäntele W, Breton J. Light-induced Fourier transform infrared (FTIR) spectroscopic investigations of primary reactions in photosystem I and photosystem II. FEBS Lett. 1986;201:151–7.View ArticleGoogle Scholar
- Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochimica Et Biophysica Sinica. 2007;39:549–59.View ArticleGoogle Scholar
- Loo YY, Chieng BW, Nishibuchi M, Radu S. Synthesis of silver nanoparticles by using tea leaf extract from Camellia sinensis. Int J Nanomedicine. 2012;7:4263–7.Google Scholar
- Singhal G, Bhavesh R, Kasariya K, Sharma AR, Singh RP. Biosynthesis of silver nanoparticles using Ocimum sanctum (Tulsi) leaf extract and screening its antimicrobial activity. J Nanoparticle Res. 2011;13:2981–8.View ArticleGoogle Scholar
- Macdonald IDG, Smith WE. Orientation of cytochrome c adsorbed on a citrate-reduced silver colloid surface. Langmuir. 1996;12:706–13.View ArticleGoogle Scholar
- Gole A, Dash C, Ramakrishnan V, Sainkar SR, Mandale AB, Rao M, et al. Pepsin-gold colloid conjugates: preparation, characterization, and enzymatic activity. Langmuir. 2001;17:1674–9.View ArticleGoogle Scholar
- Philip D, Unni C. Extracellular biosynthesis of gold and silver nanoparticles using Krishna tulsi (Ocimum sanctum) leaf. Physica E-Low-Dimensional Systems & Nanostructures. 2011;43:1318–22.View ArticleGoogle Scholar
- Bar H, Bhui DK, Sahoo GP, Sarkar P, De SP, Misra A. Green synthesis of silver nanoparticles using latex of Jatropha curcas. Colloids and Surfaces a-Physicochemical and Engineering Aspects. 2009;339:134–9.View ArticleGoogle Scholar
- Pasupuleti VR, Prasad C, Shiekh RA, Balam SK, Narasimhulu G, Reddy CS, et al. Biogenic silver nanoparticles using Rhinacanthus nasutus leaf extract: synthesis, spectral analysis, and antimicrobial studies. Int J Nanomedicine. 2013;8:3355–64.View ArticleGoogle Scholar
- Rupiasih NN, Avinash A, Suresh G, Vidyasagar PB. Green synthesis of silver nanoparticles using latex extract of Thevetia peruviana: a novel approach towards poisonous plant utilization. J Physics: Conference Series. 2013;423:012032.Google Scholar
- Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006;90:296–303.View ArticleGoogle Scholar
- Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008;101:239–53.View ArticleGoogle Scholar
- Umoren SA, Obot IB, Gasem ZM. Green synthesis and characterization of silver nanoparticles using red apple (Malus domestica) fruit extract at room temperature. J Materials Environmental Sci. 2014;5:907–14.Google Scholar
- IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.Google Scholar
- Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.View ArticleGoogle Scholar
- Haesebrouck F, Pasmans F, Flahou B, Chiers K, Baele M, Meyns T, et al. Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev. 2009;22:202–23. Table of Contents.View ArticleGoogle Scholar
- Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95–101.View ArticleGoogle Scholar
- Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–7.View ArticleGoogle Scholar
- Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6:1388–401.View ArticleGoogle Scholar
- Parashar UK, Kumar V, Bera T, Saxena PS, Nath G, Srivastava SK, et al. Study of mechanism of enhanced antibacterial activity by green synthesis of silver nanoparticles. Nanotechnology. 2011;22:415104.View ArticleGoogle Scholar
- Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol. 2010;85:1115–22.View ArticleGoogle Scholar
- Anthony KJP, Murugan M, Gurunathan S. Biosynthesis of silver nanoparticles from the culture supernatant of Bacillus marisflavi and their potential antibacterial activity. J Industrial Engineering Chemistry. 2014;20:1505–10.View ArticleGoogle Scholar
- Hwang IS, Hwang JH, Choi H, Kim KJ, Lee DG. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J Med Microbiol. 2012;61:1719–26.View ArticleGoogle Scholar
- Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177–82.View ArticleGoogle Scholar
- Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials. 2009;30:5979–87.View ArticleGoogle Scholar
- Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108.View ArticleGoogle Scholar
- Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids and Surfaces B-Biointerfaces. 2010;79:340–4.View ArticleGoogle Scholar
- Khan MM, Ansari SA, Amal MI, Lee J, Cho MH. Highly visible light active Ag@TiO2 nanocomposites synthesized using an electrochemically active biofilm: a novel biogenic approach. Nanoscale. 2013;5:4427–35.View ArticleGoogle Scholar
- Masurkar SA, Chaudhari PR, Shidore VB, Kamble SP. Effect of biologically synthesised silver nanoparticles on Staphylococcus aureus biofilm quenching and prevention of biofilm formation. IET Nanobiotechnol. 2012;6:110–4.View ArticleGoogle Scholar
- Martinez-Gutierrez F, Boegli L, Agostinho A, Sanchez EM, Bach H, Ruiz F, et al. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling. 2013;29:651–60.View ArticleGoogle Scholar
- Ninganagouda S, Rathod V, Singh D, Hiremath J, Singh AK, Mathew J, et al. Growth kinetics and mechanistic action of reactive oxygen species released by silver nanoparticles from Aspergillus niger on Escherichia coli. Biomed Research International. 2014;2014:753419.View ArticleGoogle Scholar
- Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52:662–8.View ArticleGoogle Scholar
- Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74:2171–8.View ArticleGoogle Scholar
- Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol. 2003;69:4278–81.View ArticleGoogle Scholar
- Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346–53.View ArticleGoogle Scholar
- Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005;71:7589–93.View ArticleGoogle Scholar
- Dwyer DJ, Camacho DM, Kohanski MA, Callura JM, Collins JJ. Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis. Mol Cell. 2012;46:561–72.View ArticleGoogle Scholar
- Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell. 2010;37:311–20.View ArticleGoogle Scholar
- Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797–810.View ArticleGoogle Scholar
- Morones-Ramirez JR, Winkler JA, Spina CS, Collins JJ. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med. 2013;5:190ra181.View ArticleGoogle Scholar
- Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.View ArticleGoogle Scholar
- Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306.View ArticleGoogle Scholar
- Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–19.View ArticleGoogle Scholar
- Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol. 2007;3:91.View ArticleGoogle Scholar
- Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell. 2008;135:679–90.View ArticleGoogle Scholar
- Park JH, Kim EJ, Jang HY, Shim H, Lee KK, Jo HJ, et al. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases. Oncol Rep. 2008;20:379–84.Google Scholar
- Foster KA, Galeffi F, Gerich FJ, Turner DA, Muller M. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol. 2006;79:136–71.View ArticleGoogle Scholar
- Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.View ArticleGoogle Scholar
- Sriram MI, Kalishwaralal K, Barathmanikanth S, Gurunathani S. Size-based cytotoxicity of silver nanoparticles in bovine retinal endothelial cells. Nanoscience Methods. 2012;1:56–77.View ArticleGoogle Scholar
- Almofti MR, Ichikawa T, Yamashita K, Terada H, Shinohara Y. Silver ion induces a cyclosporine a-insensitive permeability transition in rat liver mitochondria and release of apoptogenic cytochrome C. J Biochem. 2003;134:43–9.View ArticleGoogle Scholar
- Kim YJ, Yang SI, Ryu JC. Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines. Molecular Cellular Toxicol. 2010;6:119–25.View ArticleGoogle Scholar
- Zhang T, Wang L, Chen Q, Chen C. Cytotoxic potential of silver nanoparticles. Yonsei Med J. 2014;55:283–91.View ArticleGoogle Scholar
- Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briede JJ, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011;32:9810–7.View ArticleGoogle Scholar
- Song XL, Li B, Xu K, Liu J, Ju W, Wang J, et al. Cytotoxicity of water-soluble mPEG-SH-coated silver nanoparticles in HL-7702 cells. Cell Biol Toxicol. 2012;28:225–37.View ArticleGoogle Scholar
- Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, et al. Silver nanoparticles induce apoptosis and G2/M arrest via PKC zeta-dependent signaling in A549 lung cells. Arch Toxicol. 2011;85:1529–40.View ArticleGoogle Scholar
- Choi SJ, Oh JM, Choy JH. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem. 2009;103:463–71.View ArticleGoogle Scholar
- Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823–39.View ArticleGoogle Scholar
- Akhtar MJ, Ahamed M, Kumar S, Khan MAM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine. 2012;7:845–57.Google Scholar
- Gurunathan S, Han JW, Dayem AA, Eppakayala V, Park MR, Kwon DN, et al. Antibacterial activity of dithiothreitol reduced graphene oxide. J Industrial Engineering Chemistry. 2013;19:1280–8.View ArticleGoogle Scholar
- Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett. 2007;168:58–74.View ArticleGoogle Scholar
- Kimata M, Matoba S, Iwai-Kanai E, Nakamura H, Hoshino A, Nakaoka M, et al. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am J Physiology-Heart Circulatory Physiology. 2010;299:H1908–16.View ArticleGoogle Scholar
- Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis. 2007;12:815–33.View ArticleGoogle Scholar
- Han L, Du LB, Kumar A, Jia HY, Liang XJ, Tian Q, et al. Inhibitory effects of trolox-encapsulated chitosan nanoparticles on tert-butylhydroperoxide induced RAW264.7 apoptosis. Biomaterials. 2012;33:8517–28.View ArticleGoogle Scholar
- Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA. Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J Nanobiotechnology. 2013;11:5.View ArticleGoogle Scholar
- Hirsch T, Marzo I, Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 1997;17:67–76.View ArticleGoogle Scholar
- Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001;15:2922–33.Google Scholar
- Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2:2121–34.View ArticleGoogle Scholar
- Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794–807.View ArticleGoogle Scholar
- Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater. 2004;16:961−+.View ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.